91 related articles for article (PubMed ID: 9302148)
1. Variation in prostate cancer survival explained by significant prognostic factors.
Krongrad A; Lai H; Lai S
J Urol; 1997 Oct; 158(4):1487-90. PubMed ID: 9302148
[TBL] [Abstract][Full Text] [Related]
2. Marriage and mortality in prostate cancer.
Krongrad A; Lai H; Burke MA; Goodkin K; Lai S
J Urol; 1996 Nov; 156(5):1696-70. PubMed ID: 8863573
[TBL] [Abstract][Full Text] [Related]
3. Prostate-specific antigen/prostatic acid phosphatase ratio is significant prognostic factor in patients with stage IV prostate cancer.
Saito T; Hara N; Kitamura Y; Komatsubara S
Urology; 2007 Oct; 70(4):702-5. PubMed ID: 17991541
[TBL] [Abstract][Full Text] [Related]
4. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors in patients with metastatic (stage D2) prostate cancer: experience from the Scandinavian Prostatic Cancer Group Study-2.
Jørgensen T; Kanagasingam Y; Kaalhus O; Tveter KJ; Bryne M; Skjørten F; Berner A; Danielsen HE
J Urol; 1997 Jul; 158(1):164-70. PubMed ID: 9186346
[TBL] [Abstract][Full Text] [Related]
6. Association of percent positive prostate biopsies and perineural invasion with biochemical outcome after external beam radiotherapy for localized prostate cancer.
Wong WW; Schild SE; Vora SA; Halyard MY
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):24-9. PubMed ID: 15337536
[TBL] [Abstract][Full Text] [Related]
7. Serum interleukin 6 as a prognostic factor in patients with prostate cancer.
Nakashima J; Tachibana M; Horiguchi Y; Oya M; Ohigashi T; Asakura H; Murai M
Clin Cancer Res; 2000 Jul; 6(7):2702-6. PubMed ID: 10914713
[TBL] [Abstract][Full Text] [Related]
8. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.
Nieder AM; Porter MP; Soloway MS
J Urol; 2008 Nov; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517
[TBL] [Abstract][Full Text] [Related]
9. Marriage and mortality in bladder carcinoma.
Gore JL; Kwan L; Saigal CS; Litwin MS
Cancer; 2005 Sep; 104(6):1188-94. PubMed ID: 16078264
[TBL] [Abstract][Full Text] [Related]
10. The impact of marriage on bladder cancer mortality.
Nelles JL; Joseph SA; Konety BR
Urol Oncol; 2009; 27(3):263-7. PubMed ID: 18625568
[TBL] [Abstract][Full Text] [Related]
11. [Clinical studies on the prognostic factors in prostate cancer].
Horii Y; Yoshida T; Hirai S; Yamauchi T
Hinyokika Kiyo; 1998 Oct; 44(10):701-5. PubMed ID: 9850833
[TBL] [Abstract][Full Text] [Related]
12. First-year PSA kinetics and minima after prostate cancer radiotherapy are predictive of overall survival.
Cheung R; Tucker SL; Kuban DA
Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):20-4. PubMed ID: 16814948
[TBL] [Abstract][Full Text] [Related]
13. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
Słojewski M
Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics of bladder cancer in patients previously treated with radiation for prostate cancer.
Sandhu JS; Vickers AJ; Bochner B; Donat SM; Herr HW; Dalbagni G
BJU Int; 2006 Jul; 98(1):59-62. PubMed ID: 16626308
[TBL] [Abstract][Full Text] [Related]
15. Genitourinary small cell carcinoma: determination of clinical and therapeutic factors associated with survival.
Mackey JR; Au HJ; Hugh J; Venner P
J Urol; 1998 May; 159(5):1624-9. PubMed ID: 9554367
[TBL] [Abstract][Full Text] [Related]
16. Prostatic tumor relapse in patients with superficial bladder tumors: 15-year outcome.
Herr HW; Donat SM
J Urol; 1999 Jun; 161(6):1854-7. PubMed ID: 10332452
[TBL] [Abstract][Full Text] [Related]
17. Posttreatment prostatic-specific antigen doubling time as a surrogate endpoint for prostate cancer-specific survival: an analysis of Radiation Therapy Oncology Group Protocol 92-02.
Valicenti RK; DeSilvio M; Hanks GE; Porter A; Brereton H; Rosenthal SA; Shipley WU; Sandler HM;
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1064-71. PubMed ID: 16979837
[TBL] [Abstract][Full Text] [Related]
18. Marital status and survival following bladder cancer.
Datta GD; Neville BA; Kawachi I; Datta NS; Earle CC
J Epidemiol Community Health; 2009 Oct; 63(10):807-13. PubMed ID: 19468015
[TBL] [Abstract][Full Text] [Related]
19. Association of body mass index with response and survival in men with metastatic prostate cancer: Southwest Oncology Group trials 8894 and 9916.
Montgomery RB; Goldman B; Tangen CM; Hussain M; Petrylak DP; Page S; Klein EA; Crawford ED;
J Urol; 2007 Nov; 178(5):1946-51; discussion 1951. PubMed ID: 17868721
[TBL] [Abstract][Full Text] [Related]
20. Both pretreatment prostate-specific antigen level and posttreatment biochemical failure are independent predictors of overall survival after radiotherapy for prostate cancer.
Williams SG; Duchesne GM; Millar JL; Pratt GR
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1082-7. PubMed ID: 15519778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
